Intriguingly, in CRC, macrophages amplify IL-6 production from cancer cells themselves, suggesting that a substantial portion of IL-6 present in CRC’s TME might primarily be derived from the tumor cells rather than the macrophages (Gao et al., 2018). The gene discussed is IL6; the disease is colorectal carcinoma.